CPT vs UDR vs AMH
161 measures in 16 categories, one definition each, computed from filings and market data.
AMH56.3
American Homes 4 Rent
Real Estate · REIT - Residential
$31.28 +1.03%$11.2B mkt cap
Score DNA
Price, rebased to 100 three years ago
CPT UDR AMH · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 24 |
| Insider $ bought, 180d | — | — | $0.64M |
| Congress purchases, 180d | 0 | 1 | 0 |
| Last Congress purchase | — | 2026-03-27 | — |
| 13F net change in holders | +11 | −1 | +25 |
| ETFs adding shares, 30d | 536 | 526 | 296 |
| ETFs trimming, 30d | 458 | 484 | 275 |
| Net ETF funds, 30d | +78 | +42 | +21 |
Valuation
16 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| P/E (TTM) | 30.4x
56th
|
21.1x
11th
|
23.5x
22nd
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 1.63
25th
|
3.45
100th
|
2.56
50th
|
| Price / sales | 6.3x
67th
|
6.4x
75th
|
6.0x
50th
|
| Price / book | 2.6x
75th
|
3.7x
92nd
|
1.7x
33rd
|
| Price / tangible book | 3.1x
75th
|
4.4x
92nd
|
1.8x
33rd
|
| Price / free cash flow | 14.9x
50th
|
11.9x
17th
|
12.1x
25th
|
| Price / operating cash flow | 12.3x
25th
|
12.4x
33rd
|
13.0x
50th
|
| Enterprise value | $14.7B
42nd
|
$17.0B
67th
|
$16.3B
58th
|
| EV / sales | 9.4x
75th
|
9.9x
92nd
|
8.7x
58th
|
| EV / EBITDA | 13.3x
25th
|
12.9x
17th
|
13.6x
33rd
|
| EV / EBIT | 30.2x
45th
|
26.2x
36th
|
23.7x
18th
|
| EV / free cash flow | 22.1x
33rd
|
18.4x
17th
|
17.6x
8th
|
| Earnings yield | 3.3%
58th
|
4.7%
92nd
|
4.3%
83rd
|
| FCF yield | 6.7%
50th
|
8.4%
83rd
|
8.2%
75th
|
| Operating cash flow yield | 8.1%
75th
|
8.1%
67th
|
7.7%
50th
|
| Graham number (per share) | $51.61
78th
|
$18.06
22nd
|
$23.61
56th
|
Profitability (TTM)
12 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Gross margin | 22.3%
8th
|
55.7%
75th
|
30.6%
17th
|
| EBITDA margin | 70.3%
82nd
|
76.8%
91st
|
63.6%
64th
|
| Operating margin | 17.8%
17th
|
28.2%
58th
|
25.3%
42nd
|
| EBIT margin | 31.0%
55th
|
37.9%
91st
|
36.6%
82nd
|
| Net margin | 20.7%
50th
|
30.4%
92nd
|
25.5%
83rd
|
| NOPAT margin | 17.6%
17th
|
28.2%
67th
|
25.2%
42nd
|
| FCF margin | 42.3%
73rd
|
53.7%
91st
|
49.3%
82nd
|
| Operating cash flow margin | 51.3%
82nd
|
51.9%
91st
|
46.0%
73rd
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 4.9%
50th
|
5.3%
58th
|
3.5%
17th
|
| Stock comp / revenue | 1.1%
50th
|
1.6%
92nd
|
1.3%
67th
|
| Effective tax rate | 1.3%
58th
|
0.2%
42nd
|
0.6%
50th
|
Returns on capital
11 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| ROE (on average equity) | 7.8%
75th
|
16.7%
92nd
|
6.8%
42nd
|
| ROA | 3.5%
58th
|
5.0%
83rd
|
3.6%
75th
|
| ROIC | 3.2%
25th
|
5.4%
83rd
|
4.0%
33rd
|
| ROCE | 5.2%
33rd
|
7.3%
83rd
|
5.5%
50th
|
| Return on tangible assets | 5.3%
50th
|
6.2%
75th
|
5.2%
33rd
|
| Cash ROIC (OCF / invested capital) | 9.4%
58th
|
10.0%
83rd
|
7.3%
42nd
|
| Gross profitability (GP / assets) | 3.7%
8th
|
9.3%
67th
|
4.4%
17th
|
| ROIC, 3-yr average | 3.3%
45th
|
2.8%
36th
|
3.6%
64th
|
| ROIC, 5-yr average | 4.5%
73rd
|
2.9%
36th
|
3.4%
64th
|
| ROE, 5-yr average | 8.1%
73rd
|
8.1%
64th
|
5.4%
55th
|
| Incremental ROIC | 51.8%
67th
|
-101.3%
8th
|
-12.7%
25th
|
Growth
17 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Revenue growth (TTM YoY) | 0.8%
17th
|
1.5%
42nd
|
4.5%
58th
|
| Revenue growth (QoQ) | 1.2%
75th
|
-0.1%
17th
|
-0.4%
8th
|
| Revenue CAGR, 3 yr | 1.3%
36th
|
2.5%
55th
|
6.3%
82nd
|
| Revenue CAGR, 5 yr | 8.0%
55th
|
7.0%
45th
|
8.8%
91st
|
| Gross profit CAGR, 3 yr | -28.2%
9th
|
36.6%
100th
|
-12.2%
18th
|
| Operating income CAGR, 3 yr | -2.1%
55th
|
-7.6%
27th
|
-15.2%
18th
|
| Net income growth (TTM YoY) | 109.1%
78th
|
295.8%
100th
|
12.2%
44th
|
| Net income CAGR, 3 yr | 16.1%
100th
|
5.3%
43rd
|
9.2%
57th
|
| EPS growth (TTM YoY) | 123.5%
78th
|
303.4%
100th
|
14.8%
44th
|
| EPS CAGR, 3 yr | 18.7%
100th
|
6.1%
43rd
|
9.2%
57th
|
| EPS CAGR, 5 yr | 20.7%
75th
|
97.0%
100th
|
20.0%
62nd
|
| FCF growth (TTM YoY) | 60.7%
100th
|
55.0%
91st
|
32.8%
73rd
|
| FCF CAGR, 3 yr | 19.9%
70th
|
20.3%
80th
|
19.0%
60th
|
| Operating cash flow CAGR, 3 yr | 1.1%
36th
|
2.3%
45th
|
7.2%
82nd
|
| Book value CAGR, 3 yr | -6.2%
36th
|
-10.0%
18th
|
-0.3%
82nd
|
| Dividend CAGR, 3 yr | 10.2%
100th
|
-92.6%
0th
|
3.5%
82nd
|
| Sustainable growth rate | -5.9%
11th
|
16.7%
100th
|
0.0%
78th
|
Margin history & stability
7 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Gross margin, 3-yr average | 48.4%
45th
|
35.5%
0th
|
47.2%
36th
|
| Operating margin, 3-yr average | 19.0%
18th
|
22.5%
36th
|
39.9%
100th
|
| Net margin, 3-yr average | 18.8%
55th
|
15.5%
45th
|
23.7%
82nd
|
| FCF margin, 3-yr average | 30.8%
55th
|
40.5%
82nd
|
42.9%
91st
|
| Revenue stability (0-1) | 0.75
36th
|
0.85
55th
|
0.98
73rd
|
| Earnings stability (0-1) | 0.03
18th
|
0.33
64th
|
0.94
82nd
|
| Margin stability (0-1) | 0.67
18th
|
0.48
9th
|
0.78
36th
|
Liquidity (latest quarter)
7 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Cash & short-term investments | $44.7M
50th
|
$1.2M
0th
|
$83.7M
83rd
|
| Net cash (− = net debt) | −$4.8B
42nd
|
−$6.0B
17th
|
−$5.1B
33rd
|
| Working capital | $51.6M
67th
|
−$1.2B
0th
|
$312.2M
83rd
|
| Current ratio | 45.10
100th
|
0.15
9th
|
1.61
64th
|
| Quick ratio | 45.10
100th
|
0.15
9th
|
1.61
64th
|
| Cash ratio (cash + ST investments / current liabilities) | 38.22
100th
|
0.00
0th
|
0.16
25th
|
| Defensive interval (days) | 271 days
60th
|
134 days
30th
|
473 days
90th
|
Leverage & solvency (latest quarter)
13 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Total debt | $4.8B
58th
|
$6.0B
83rd
|
$5.1B
67th
|
| Debt / equity | 1.28
67th
|
2.04
92nd
|
0.76
25th
|
| Net debt / equity | 1.26
67th
|
2.04
92nd
|
0.74
25th
|
| Debt / assets | 51.3%
58th
|
58.4%
92nd
|
39.3%
17th
|
| Debt / capital | 56.0%
67th
|
67.1%
92nd
|
43.1%
25th
|
| Debt / EBITDA | 4.39
25th
|
4.55
50th
|
4.30
17th
|
| Net debt / EBITDA | 4.35
33rd
|
4.54
50th
|
4.23
8th
|
| Interest coverage (EBIT / interest) | 3.3x
75th
|
3.3x
83rd
|
3.4x
92nd
|
| Cash interest coverage | 5.5x
83rd
|
4.5x
67th
|
4.2x
42nd
|
| Debt payback (years of OCF) | 6.0 yrs
42nd
|
6.7 yrs
58th
|
6.0 yrs
33rd
|
| Liabilities / assets | 59.0%
75th
|
71.4%
92nd
|
43.2%
17th
|
| IS credit model rating | BBB+ | B+ | BBB |
| Implied credit spread (bps) | 225
8th
|
650
75th
|
275
25th
|
Efficiency
11 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Asset turnover | 0.17
75th
|
0.16
67th
|
0.14
33rd
|
| Fixed asset turnover | — | 0.19
57th
|
0.16
14th
|
| Inventory turnover | — | — | — |
| Receivables turnover | 185.7
100th
|
10.9
22nd
|
39.2
89th
|
| Days sales outstanding | 2 days
25th
|
34 days
83rd
|
9 days
33rd
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 68 days
83rd
|
57 days
75th
|
0 days
33rd
|
| Cash conversion cycle (days) | −66 days
18th
|
−23 days
36th
|
9 days
73rd
|
| Capex / revenue | 9.0%
70th
|
— | — |
| Capex / depreciation | 0.23
56th
|
— | — |
| Operating expense ratio | — | 44.7%
50th
|
31.8%
12th
|
Cash flow & earnings quality
7 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Operating cash flow / net income | 2.48
44th
|
1.71
11th
|
1.81
22nd
|
| FCF / net income | 2.04
67th
|
1.76
44th
|
1.94
56th
|
| FCF / operating cash flow | 82.5%
50th
|
— | — |
| Capex / operating cash flow | 17.5%
50th
|
— | — |
| Accruals ratio | -5.2%
42nd
|
-3.5%
75th
|
-2.9%
100th
|
| Sloan accruals ratio | 3.3%
83rd
|
-12.9%
8th
|
-1.7%
58th
|
| Earnings quality score (0-1) | 0.75
0th
|
1.00
44th
|
1.00
44th
|
Scores & forensic checks
15 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| IS score | 50
58th
|
56
75th
|
56
67th
|
| IS profitability | 23
8th
|
64
83rd
|
62
75th
|
| IS growth | 57
58th
|
58
75th
|
51
42nd
|
| IS value | 54
67th
|
49
50th
|
53
58th
|
| IS momentum | 85
67th
|
86
75th
|
80
50th
|
| IS risk (safety) | 30
42nd
|
15
0th
|
30
42nd
|
| IS quality | 59
25th
|
70
58th
|
81
92nd
|
| IS balance sheet | 40
58th
|
23
8th
|
48
92nd
|
| IS earnings quality | 89
58th
|
83
42nd
|
92
92nd
|
| IS cash flow | 84
67th
|
86
92nd
|
86
83rd
|
| Piotroski F-score (0-9) | 6
33rd
|
7
67th
|
8
100th
|
| Altman Z-score | 1.4
58th
|
0.7
8th
|
1.6
75th
|
| Beneish M-score | −5.11
0th
|
−3.14
64th
|
−3.13
73rd
|
| Ohlson O-score | −7.65
42nd
|
−6.39
83rd
|
−8.58
8th
|
| IS credit score | 64
92nd
|
35
25th
|
60
75th
|
Size (TTM)
8 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| Market cap | $9.9B
42nd
|
$11.0B
50th
|
$11.2B
58th
|
| Revenue | $1.6B
42nd
|
$1.7B
58th
|
$1.9B
67th
|
| EBITDA | $1.1B
58th
|
$1.3B
92nd
|
$1.2B
67th
|
| Net income | $326.2M
42nd
|
$522.2M
92nd
|
$478.5M
83rd
|
| Free cash flow | $665.9M
50th
|
$921.6M
67th
|
$926.4M
75th
|
| Total assets | $9.5B
42nd
|
$10.3B
58th
|
$13.1B
92nd
|
| Shareholders' equity | $3.8B
50th
|
$2.9B
33rd
|
$6.8B
92nd
|
| Employees | 1,640
58th
|
1,420
42nd
|
1,598
50th
|
Price performance
9 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| 1 day | +0.4% | +0.1% | +1.0% |
| 1 week | +1.1% | +0.3% | +1.4% |
| 1 month | −1.2% | +0.1% | +0.0% |
| 3 months | −12.6% | −13.8% | −7.2% |
| 6 months | −4.6% | −3.0% | +2.0% |
| Year to date | −10.5% | −5.6% | −2.0% |
| 1 year | −2.1% | −5.5% | −3.0% |
| 3 years, cumulative | +10.2% | +1.4% | −4.6% |
| 5 years, cumulative | −24.2% | −24.4% | −8.4% |
Technicals
4 measures| Measure | CPT | UDR | AMH |
|---|---|---|---|
| RSI 14 | 47.3 | 47.3 | 53.2 |
| From 52-week high | −17.7% | −18.2% | −10.8% |
| From 52-week low | +3.5% | +4.0% | +14.9% |
| Beta | 0.81 | 0.71 | 0.79 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17